We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDP
RNS Number : 4115V
InnovaDerma PLC
30 January 2017
InnovaDerma PLC
("InnovaDerma" or the "Company")
Directorate Change
InnovaDerma (LON: IDP), a UK developer of 'at-home' and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, is pleased to announce the appointment of Kieran Callan as a Non-Executive Director with immediate effect, succeeding Garry Lemair who stepped down from the Board on 10 January 2017.
Mr. Callan has more than 30 years of experience in the FMCG and retail sector with a strong track record of devising and implementing strategies for growth companies. He also brings with him extensive experience in M&A including deal execution and integration of acquired businesses. He holds a BA (Hons) Law, Post Graduate Diploma in Marketing and is a Fellow of the Australian Institute of Company Directors.
Since 2012, Mr. Callan has been the Chief Executive Officer of Joval Group Pty Ltd, a company engaged in the production, distribution, warehousing and logistics of fine wine and food to both the Australian domestic and international markets. In 2008, he became the founding Melbourne Director of the National Australia Bank private equity business aimed at small and medium enterprises for the provision of capital to facilitate growth. Mr.Callan spent six years at PZ Cussons Plc from 1994 to 2000 where he held various senior management roles including Managing Director of Cussons (UK) Ltd and Managing Director of Cussons Pty Ltd (Australia) where he was responsible for revitalising its operations and delivering revenue and profit growth across its core UK, Australian and Indonesian businesses.
As previously announced on 10 January 2017, Mr. Callan will replace Clifford Giles on the Audit Committee, Nomination Committee and Remuneration Committee. Clifford Giles will continue to serve as a Non-Executive Director of the Company.
Mr. Callan currently does not hold any directorships on the board of any publicly quoted companies and there are no further details that need to be disclosed in accordance with Listing Rule 9.6.13.
Haris Chaudhry, Executive Chairman said:
"I am delighted to welcome Kieran to the Board and that we have managed to secure the appointment of someone of his calibre and experience. Kieran brings with him extensive experience and an excellent track record in growing businesses and market knowledge. We look forward to working with him to continue to build on our success and scale our business further."
Kieran Callan, said:
"InnovaDerma is a great business, with a unique product range and strong foundations which will enable the Company to generate long term growth. I am delighted to have taken this role and look forward to contributing to the business."
Further enquiries:
InnovaDerma Haris Chaudhry/Joe Bayer +61 (0)3 9111 0071 --------------------------- ----------------------- Sole broker Hybridan LLP Claire Noyce +44 (0)203 764 2341 --------------------------- ----------------------- Cardew Group Shan Shan Willenbrock David Roach Emma Ruttle + 44 (0)20 7930 0777 --------------------------- -----------------------
About InnovaDerma:
InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the UK, US, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.
www.innovaderma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOASEWFLAFWSESF
(END) Dow Jones Newswires
January 30, 2017 02:01 ET (07:01 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions